Corporate ActionMay 18, 2026, 04:32 PM
Daré Bioscience Completes $250K Regulation A Offering Closings
AI Summary
Daré Bioscience, Inc. completed the closings of its previously announced Regulation A offering on May 14, 2026. The company issued an aggregate of 50,000 Investor Units, each priced at $5.00, resulting in total proceeds of $250,000 from these closings. Each Investor Unit consists of one share of Series A Convertible Preferred Stock and two warrants to purchase one share of common stock, leading to the issuance of 50,000 Series A Preferred shares and warrants for up to 100,000 common shares.
Key Highlights
- Completed closings of Regulation A offering on May 14, 2026.
- Issued 50,000 Investor Units at an offering price of $5.00 per unit.
- Total proceeds from this closing amount to $250,000.
- Each Investor Unit includes one Series A Convertible Preferred Stock share.
- Each Investor Unit includes two warrants to purchase common stock.
- Issued 50,000 shares of Series A Preferred Stock.
- Issued Investor Warrants to purchase up to 100,000 shares of common stock.
Price Impact
More from DARE